Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY

v3.20.4
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment [Member]
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment [Member]
Total
Balance at Dec. 31, 2017 $ 50 $ 24,276 $ 117,827,839   $ (96,472,452)   $ 21,379,713
Balance (in shares) at Dec. 31, 2017 49,626 24,276,275          
Exercise of Warrants   $ 84 39,289       39,373
Exercise of warrants (in shares)   84,210          
Settlement of Derivative Liability upon Exercise of Warrants     166,800       166,800
Exercise of Stock Options   $ 41 (41)        
Stocks issued due to exercise of Stock Options (in shares)   41,111          
Stock-Based Compensation Expense   $ 28 1,620,450       1,620,478
Stock-Based Compensation Expense (in shares)   27,915          
Proceeds from Common Stock Offerings   $ 3,000 29,997,000       30,000,000
Proceeds from Common Stock Offerings (in shares)   3,000,000          
Direct Costs of Common Stock Offerings     (1,975,000)       (1,975,000)
Common Stock Issued for Services   $ 17 99,983       100,000
Common Stock Issued for Services (in shares)   17,159          
Common Stock Awards   $ 145 919,455       919,600
Common Stock Awards (in shares)   145,000          
Net Loss         (21,875,713)   (21,875,713)
Balance at Dec. 31, 2018 $ 50 $ 27,591 148,695,775 $ 81,724 (118,266,441) $ 81,724 30,456,975
Balance (in shares) at Dec. 31, 2018 49,626 27,591,670          
Stock-Based Compensation Expense   $ 58 1,404,773       1,404,831
Stock-Based Compensation Expense (in shares)   57,496          
Proceeds from Common Stock Offerings   $ 5,479 19,994,528       20,000,007
Proceeds from Common Stock Offerings (in shares)   5,479,454          
Direct Costs of Common Stock Offerings     (1,145,000)       (1,145,000)
Net Loss         (26,476,370)   (26,476,370)
Balance at Dec. 31, 2019 $ 50 $ 33,128 168,950,076   (144,742,811)   24,240,443
Balance (in shares) at Dec. 31, 2019 49,626 33,128,620          
Exercise of Warrants   $ 2,883 14,125,644       14,128,527
Exercise of warrants (in shares)   2,882,647          
Exercise of Stock Options   $ 44 29,176       29,220
Stocks issued due to exercise of Stock Options (in shares)   43,854          
Stock-Based Compensation Expense   $ 943 2,656,888       2,657,831
Stock-Based Compensation Expense (in shares)   942,986          
Proceeds from Common Stock Offerings   $ 8,647 26,741,355       26,750,002
Proceeds from Common Stock Offerings (in shares)   8,647,059          
Direct Costs of Common Stock Offerings     (1,550,666)       (1,550,666)
Net Loss         (17,952,172)   (17,952,172)
Balance at Dec. 31, 2020 $ 50 $ 45,645 $ 210,952,473   $ (162,694,983)   $ 48,303,185
Balance (in shares) at Dec. 31, 2020 49,626 45,645,166